COVID-19-induced coagulopathy: Experience, achievements, prospects

The presence of coagulopathy as part of the systemic inflammatory response syndrome is a characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological changes (increased D-dimer [DD], prolonged activated partial thromboplastin clotting time [APTT] and prothrombin time [PT], hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubey, Leonid, Dorosh, Olga, Dubey, Nataliya, Doan, Svitlana, Kozishkurt, Olena, Duzenko, Oleksandr, Kozlova, Olena, Ievtukh, Veronika, Ladny, Jerzy R., Pruc, Michal, Szarpak, Lukasz, Pukach, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2022
Materias:
Covid-19: Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287077/
https://www.ncbi.nlm.nih.gov/pubmed/36588310
http://dx.doi.org/10.5603/CJ.a2022.0123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287077/
https://www.ncbi.nlm.nih.gov/pubmed/36588310
http://dx.doi.org/10.5603/CJ.a2022.0123

Ejemplares similares